The Efficacy of Denosumab in Incomplete Patients Spinal Cord Injury

NCT03029442 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

5

Enrollment

FED

Sponsor class

Stopped Study ended early due to COVID-19

Conditions

Secondary Osteoporosis
Spinal Cord Injury

Interventions

DRUG: Denosumab (Prolia)
OTHER: Placebo (normal saline)

Sponsor

James J. Peters Veterans Affairs Medical Center

Collaborators

[object Object]